181 related articles for article (PubMed ID: 37646828)
1. The ALKBH5/SOX4 axis promotes liver cancer stem cell properties via activating the SHH signaling pathway.
Yang Q; Liang Y; Shi Y; Shang J; Huang X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15499-15510. PubMed ID: 37646828
[TBL] [Abstract][Full Text] [Related]
2. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
[TBL] [Abstract][Full Text] [Related]
3. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
4. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
5. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.
Hao F; Wang N; Zhang Y; Xu W; Chen Y; Fei X; Wang J
Mol Carcinog; 2022 Nov; 61(11):975-988. PubMed ID: 35924788
[TBL] [Abstract][Full Text] [Related]
6. PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer.
Wu J; Tan HY; Chan YT; Lu Y; Feng Z; Yuan H; Zhang C; Feng Y; Wang N
J Exp Clin Cancer Res; 2024 Feb; 43(1):42. PubMed ID: 38317186
[TBL] [Abstract][Full Text] [Related]
7. ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.
You Y; Wen D; Zeng L; Lu J; Xiao X; Chen Y; Song H; Liu Z
Int J Biol Sci; 2022; 18(13):5001-5018. PubMed ID: 35982895
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5-mediated m
Chen Y; Zhou P; Deng Y; Cai X; Sun M; Sun Y; Wu D
Clin Transl Med; 2023 Feb; 13(2):e1198. PubMed ID: 36792369
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling.
Gu Y; Wang Y; He L; Zhang J; Zhu X; Liu N; Wang J; Lu T; He L; Tian Y; Fan Z
Mol Cancer; 2021 Oct; 20(1):132. PubMed ID: 34649567
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma.
Bhuria V; Xing J; Scholta T; Bui KC; Nguyen MLT; Malek NP; Bozko P; Plentz RR
Exp Cell Res; 2019 Dec; 385(2):111671. PubMed ID: 31634481
[TBL] [Abstract][Full Text] [Related]
11. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
12. The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling.
Wu J; Zhu P; Lu T; Du Y; Wang Y; He L; Ye B; Liu B; Yang L; Wang J; Gu Y; Lan J; Hao Y; He L; Fan Z
J Hepatol; 2019 May; 70(5):918-929. PubMed ID: 30582981
[TBL] [Abstract][Full Text] [Related]
13. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
14. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
15. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
[TBL] [Abstract][Full Text] [Related]
16. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
[TBL] [Abstract][Full Text] [Related]
17. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.
Chen ZZ; Huang L; Wu YH; Zhai WJ; Zhu PP; Gao YF
Nat Commun; 2016 Aug; 7():12598. PubMed ID: 27553854
[TBL] [Abstract][Full Text] [Related]
18. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
19. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
20. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines
Hu YT; Li BF; Zhang PJ; Wu D; Li YY; Li ZW; Shen L; Dong B; Gao J; Zhu X
World J Gastroenterol; 2019 Feb; 25(8):923-940. PubMed ID: 30833799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
